# N-acetylcysteine to Reduce Ischemia/Reperfusion Injury in Liver Resection

> **NCT01223326** · PHASE4 · COMPLETED · sponsor: **Clinica Universidad de Navarra, Universidad de Navarra** · enrollment: 46 (actual)

## Conditions studied

- Hepatectomy
- Reperfusion Injury

## Interventions

- **DRUG:** Acetylcysteine (NAC)
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT01223326
- **Lead sponsor:** Clinica Universidad de Navarra, Universidad de Navarra
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-01
- **Primary completion:** 2007-10
- **Final completion:** 2007-12
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2012-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01223326

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01223326, "N-acetylcysteine to Reduce Ischemia/Reperfusion Injury in Liver Resection". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01223326. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*